Aldeyra Therapeutics
ALDX
$3.93
Share price
-0.25%
Change (1 day)
-58.76%
Change (1 year)
Categories
Aldeyra Therapeutics (ALDX) - Cash on Hand
Cash on Hand as of December 2023 : $0.14 B
According to Aldeyra Therapeutics
's latest financial reports the company has $0.14 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Aldeyra Therapeutics - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | -18.06% |
| 2022-12-31 | $0.17 B | -24.15% |
| 2021-12-31 | $0.22 B | 195.14% |
| 2020-12-31 | $77.85 M | 6.13% |
| 2019-12-31 | $73.36 M | -21.62% |
| 2018-12-31 | $93.59 M | 117.94% |
| 2017-12-31 | $42.94 M | 72.39% |
| 2016-12-31 | $24.91 M | -9.71% |
| 2015-12-31 | $27.59 M | 223.56% |
| 2014-12-31 | $8.52 M | 161.38% |
| 2013-12-31 | $3.26 M | 166.61% |
| 2012-12-31 | $1.22 M | 387.59% |
| 2011-12-31 | $0.25 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $10.84 B | 7,493.17% | 🇺🇸 USA |